There are consumers all across the U.S. who swear by the popular cough/cold product Airborne. Despite its popularity, the company has been hit with a $30 million fine by the Federal Trade Commission for claiming Airborne can help reduce the length of a common cold. Will the Airborne brand's settlement with the Federal Trade Commission have an impact on the product's sales?

REGISTRATION ONLY TAKES A MINUTE!
To read the complete content of this article and participate in the discussion, click the button below and sign up now! Existing subscribers, use the login below.